We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Improving Cardiovascular Treatment Approaches Among Minorities

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00101478
Recruitment Status : Completed
First Posted : January 11, 2005
Last Update Posted : March 30, 2017
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Maryland

Brief Summary:
The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, the study will aim to improve provider and patient approaches to treatment of hypertension and diabetes, respectively.

Condition or disease
Cardiovascular Diseases Heart Diseases Diabetes Mellitus Hypertension

  Show Detailed Description

Study Type : Observational
Actual Enrollment : 823 participants
Observational Model: Case-Control
Time Perspective: Other
Official Title: Partnership Programs to Reduce Cardiovascular Disparities - Baltimore Partnership
Actual Study Start Date : September 2004
Primary Completion Date : January 2011
Study Completion Date : January 2011

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
The study groups will be selected from primary and family health clinics, community, and patients of physicians participating in the study.

Inclusion Criteria:

  • Uncontrolled hypertension or diabetes

Exclusion Criteria:

  • Medical condition that would prevent treatment for hypertension at the University of Maryland
  • Medical condition that would prevent treatment for diabetes at Bon Secours
  • Uninsured

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00101478

United States, Maryland
University of Maryland Baltimore
Baltimore, Maryland, United States, 21201
Bon Secours Hospital
Baltimore, Maryland, United States, 21223
Sponsors and Collaborators
University of Maryland
National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Elijah Saunders, MD University of Maryland
Principal Investigator: Reed Winston, MD Bon Secours Hospital Baltimore
Principal Investigator: Fadia T. Shaya, PhD, MPH Universitiy of Maryland Baltimore
Principal Investigator: Wallace R. Johnson, MD Bon Secours Hospital Baltimore

Responsible Party: University of Maryland
ClinicalTrials.gov Identifier: NCT00101478     History of Changes
Other Study ID Numbers: HP-00040555
U01HL079151 ( U.S. NIH Grant/Contract )
First Posted: January 11, 2005    Key Record Dates
Last Update Posted: March 30, 2017
Last Verified: March 2017

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases